幽门螺杆菌工程疫苗研究进展

　　［15］Tricerri A,Guidi L,Frasca D,Costanzo M,Errani AR,Riccioni ME,Barattini p,Vangeli M,Bartoloni C,Coppola R,Doria G,Characteristics of gastric-vein lymphocytes with regard to the immune response to Helicobacter pylori.Scand J gastroenterol,1999;34:757-764

　　［16］范学工，刘片波，幽门螺杆菌感染的免疫发病机制，华人消化杂志，1998；6：155-157

　　［17］Mohammadi M,Nedrud J,Redline R,Guidi L,Frasca D,Costanzo M,Murine CD4 T cell response to Helicobacter infection:Th1 cells enhance gastritis and Th2 cells

　　［18］Tytgat GN Long term consequences of Helicobacter pylori eradication.Scand J Gastroenterol,1994;205(Suppl):238

　　［19］Van der Hulst RWM, Keller JJ, Rauws EAJ, Killeen KP,Hohmann EL,Treatment of Helicobacter pylori infection:a review of the world literature.Helicobacter,1996;1:6-11

　　［20］Mastroeni P,Bowe F,Cahill R,Simmons C,Dougan G.Vaccines against gut pathogens.Gut,1999;45:633-635

　　［21］Oscar G,Pricerri A,Guidi K.The attenunated Salmonella vaccine approach for the control Helicobacter pylori-related diseases.Vaccine,1999;17:1667-1673

　　［22］DiPetrillo MD,Tibbetts T,Kleanthous H,Killeen KP,Hohmann EL.Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers.Vaccine,1999;18:

　　［23］Gomez-Duarte OG,Lucas B,Yan Z,Shachter R,Parsonnet J,Urease subunits A and B delivered by attenuated Salmonella typhimurium vaccine strain protects mice against gastric co;onization by Helicobacter pylor.Vaccine,1998;16:460-471

　　［24］Corthesy IE,Hopkins S,Bachman D,Frank R,Gross R,Goebel W.Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurim phoPc expressing urease A and B subunits.Infect immune,1998;66:581-586

　　［25］Lee A Vaccines.Eur J Gastroe

上一页  [1] [2] [3] [4] [5] [6] 下一页